Amphastar Pharmaceuticals Inc (AMPH) - Financial and Strategic SWOT Analysis Review

  • ID: 4225245
  • SWOT Analysis
  • 48 pages
  • GlobalData
  • Amphastar Pharmaceuticals Inc
1 of 5

FEATURED COMPANIES

  • Akorn Inc
  • Fresenius Kabi USA LLC
  • Mylan Inc
  • Sandoz Inc
  • MORE
Amphastar Pharmaceuticals Inc (AMPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Amphastar Pharmaceuticals Inc (Amphastar) is a specialty pharmaceutical company that develops, manufactures and markets generic and proprietary injectable, intranasal and inhalation products. It also sells insulin active pharmaceutical ingredient (insulin API) products. The company’s products includes enoxaparin sodium injection; cosyntropin for injection; naloxone hydrochloride (HCl) injection and phytonadione injection; ketorolac tromethamine injection; lidocaine HCl jelly 2%; amphadase hyaluronidase injection; lidocaine HCl 4% topical solution and Luer-Jet prefilled disposable syringes;. Amphastar’s offers its products to alternate care sites, hospitals, clinics and doctors’ offices and long-term care facilities. The company markets its products through subsidiaries, specialty distributors, wholesalers and retailers in the US, the UK, France and China. Amphastar is headquartered in Rancho Cucamonga, California, the US.

Amphastar Pharmaceuticals Inc Key Recent Developments

Mar 21, 2018: Amphastar Announces Final Judgment in the Patent Litigation against Momenta Pharmaceuticals and Sandoz
Mar 12, 2018: Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Fiscal Year Ended December 31, 2017
Nov 08, 2017: Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2017
Aug 09, 2017: Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2017
May 08, 2017: Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2017

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Akorn Inc
  • Fresenius Kabi USA LLC
  • Mylan Inc
  • Sandoz Inc
  • MORE
Section 1 - About the Company
  • Amphastar Pharmaceuticals Inc - Key Facts
  • Amphastar Pharmaceuticals Inc - Key Employees
  • Amphastar Pharmaceuticals Inc - Key Employee Biographies
  • Amphastar Pharmaceuticals Inc - Major Products and Services
  • Amphastar Pharmaceuticals Inc - History
  • Amphastar Pharmaceuticals Inc - Company Statement
  • Amphastar Pharmaceuticals Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Amphastar Pharmaceuticals Inc - Business Description
  • Business Segment: Finished Pharmaceutical Products
  • Overview
  • Performance
  • Business Segment: Insulin API
  • Overview
  • Performance
  • Geographical Segment: France
  • Performance
  • Geographical Segment: The US
  • Performance
  • R&D Overview
  • Amphastar Pharmaceuticals Inc - Corporate Strategy
  • Amphastar Pharmaceuticals Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Amphastar Pharmaceuticals Inc - Strengths
  • Amphastar Pharmaceuticals Inc - Weaknesses
  • Amphastar Pharmaceuticals Inc - Opportunities
  • Amphastar Pharmaceuticals Inc - Threats
  • Amphastar Pharmaceuticals Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Amphastar Pharmaceuticals Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Mar 21, 2018: Amphastar Announces Final Judgment in the Patent Litigation against Momenta Pharmaceuticals and Sandoz
  • Mar 12, 2018: Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Fiscal Year Ended December 31, 2017
  • Nov 08, 2017: Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2017
  • Aug 09, 2017: Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2017
  • May 08, 2017: Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2017
  • Mar 13, 2017: Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Fiscal Year Ended December 31, 2016
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • Amphastar Pharmaceuticals Inc, Key Facts
  • Amphastar Pharmaceuticals Inc, Key Employees
  • Amphastar Pharmaceuticals Inc, Key Employee Biographies
  • Amphastar Pharmaceuticals Inc, Major Products and Services
  • Amphastar Pharmaceuticals Inc, History
  • Amphastar Pharmaceuticals Inc, Other Locations
  • Amphastar Pharmaceuticals Inc, Subsidiaries
  • Amphastar Pharmaceuticals Inc, Key Competitors
  • Amphastar Pharmaceuticals Inc, Ratios based on current share price
  • Amphastar Pharmaceuticals Inc, Annual Ratios
  • Amphastar Pharmaceuticals Inc, Annual Ratios
  • Amphastar Pharmaceuticals Inc, Annual Ratios
  • Amphastar Pharmaceuticals Inc, Interim Ratios
  • Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Amphastar Pharmaceuticals Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Amphastar Pharmaceuticals Inc, Performance Chart (2013-2017)
  • Amphastar Pharmaceuticals Inc, Ratio Charts
  • Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Teva Pharmaceutical Industries Ltd
  • Sandoz Inc
  • Sagent Pharmaceuticals Inc
  • Mylan Inc
  • Fresenius Kabi USA LLC
  • Akorn Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll